Allan Camaisa
Director · Calidi Biotherapeutics, Inc.
- 2024
- Dec 16, 2025
- 2
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Allan Camaisa. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Scott Leftwich - $250K in CLDI purchases and sales on record
- James A. Schoeneck - $150K in CLDI purchases and sales on record
- Eric E. Poma - $50K in CLDI purchases and sales on record
- Andrew C. Jackson - $5K in CLDI purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Allan Camaisa?
Allan Camaisa is a corporate insider, tracked as Director of Calidi Biotherapeutics, Inc. (CLDI). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Allan Camaisa last file a Form 4?
The most recent primary Form 4 on record is dated 16 December 2025, one of 2 filings going back to 2024.
Has Allan Camaisa been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($17K) across all tracked filings.
